Nikolaos Chaleplidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nikolaos Chaleplidis has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Adam Mylonakis
First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, 11527 Athens, Greece
1 shared publication - Areti Kalfoutzou
Department of Medical Oncology, 251 Air Force General Hospital, Athens, GRC
1 shared publication - Christos Piperis
Department of Biomedical Engineering, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece
1 shared publication Eleftheria Bagiokou
Department of Medical Oncology, 251 Air Force General Hospital, Athens, Greece
1 shared publication- Eleni Mostratou
Second Department of Internal Medicine, 251 Air Force General Hospital, Athens, Greece
1 shared publication - Konstantinos Kounouklas
Second Department of Internal Medicine, 251 Air Force General Hospital, Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 18 December 2025
- Published by Pensoft Publishers in Folia Medica
- Vol. 67 (6)
Echoes of a hidden killer: a case of oral and cardiac amyloidosis
Light chain amyloidosis (AL) is a rare systemic disorder caused by the accumulation of immunoglobulin light chains in various organs, most notably the heart. Its clinical presentation is often nonspecific, leading to delayed diagnosis and poor prognosis. We report the case of a 71-year-old woman who presented with macroglossia and periorbital ecchymosis, symptoms that persisted for six years before diagnosis, along with dyspnea on exertion for the past year. Comprehensive evaluation revealed AL amyloidosis with significant cardiac involvement, evidenced by echocardiographic findings of concentric ventricular wall thickening and diastolic dysfunction consistent with restrictive cardiomyopathy. Laboratory workup confirmed elevated serum free light chains (FLC), and histopathology demonstrated the presence of amyloid deposits confirming the diagnosis. This case acknowledges cardiac AL amyloidosis as a rare cause of cardiac failure with preserved ejection fraction, often accompanied by systemic manifestations of the disease such as macroglossia and periorbital ecchymosis, and highlights the critical need for high clinical suspicion and early recognition of cardiac involvement in AL patients.
- 18 December 2025
- Published by Pensoft Publishers in Folia Medica
- Vol. 67 (6)
Open AccessEchoes of a hidden killer: a case of oral and cardiac amyloidosis
Light chain amyloidosis (AL) is a rare systemic disorder caused by the accumulation of immunoglobulin light chains in various organs, most notably the heart. Its clinical presentation is often nonspecific, leading to delayed diagnosis and poor prognosis. We report the case of a 71-year-old woman who presented with macroglossia and periorbital ecchymosis, symptoms that persisted for six years before diagnosis, along with dyspnea on exertion for the past year. Comprehensive evaluation revealed AL amyloidosis with significant cardiac involvement, evidenced by echocardiographic findings of concentric ventricular wall thickening and diastolic dysfunction consistent with restrictive cardiomyopathy. Laboratory workup confirmed elevated serum free light chains (FLC), and histopathology demonstrated the presence of amyloid deposits confirming the diagnosis. This case acknowledges cardiac AL amyloidosis as a rare cause of cardiac failure with preserved ejection fraction, often accompanied by systemic manifestations of the disease such as macroglossia and periorbital ecchymosis, and highlights the critical need for high clinical suspicion and early recognition of cardiac involvement in AL patients.